Citius Pharmaceuticals Inc (NASDAQ:CTXR) traded at $0.66 at close of the session on Friday, April 26, made a downward move of -9.25% on its previous day’s price.
Looking at the stock we see that its previous close was $0.73 . In terms of its 52-week price range, CTXR has a high of $1.56 and a low of $0.60. The company’s stock has lost about -19.33% over that past 30 days.
Citius Pharmaceuticals Inc has a market cap of $105.76 million. Estimates by analysts give the company expected earnings per share (EPS) of -$0.05, with the EPS growth for the year raised at -$0.21 for 2024 and $0.12 for next year. These figures represent 4.50% and 157.10% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $14.81 million, with a high of $44.44 million.
On the other hand, looking at the outlook for the CTXR stock, short term indicators assign the stock an average of 50% Buy, while medium term indicators assign it an average of Hold. Long term indicators on average place the stock in the category of 100% Sell.
Looking further, we note the current price level is -21.70% off its SMA20 and -16.39% from its 50-day simple moving average. The RSI (14) is pointing at 36.97 while the volatility over the past week is 8.55% and jumps to 11.92% over the past one month. The beta value is 1.55, while the average true range (ATR) is currently pointing at 0.08.
Coming back to Citius Pharmaceuticals Inc (NASDAQ:CTXR), we note that the average 3-month trading volume was 842.91K. Current shares outstanding are 158.86 million.
The insiders hold 7.74% of the company’s shares while institutions hold 17.01%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -12.12% down in year-to-date price movement.
